Skip to main content Back to Top

GLP Practice Insights: GLP-1 Receptor Agonist’s Role in Mental Health and Substance Use Disorders (CE)

May 16, 2026


ABOUT THIS PODCAST

This podcast is a brief review of emerging literature focusing on the potential use of GLP-1 receptor agonists in the treatment of mental health and substance use disorders. The episode explores how GLP-1 receptor agonists work to alter neurotransmitter systems and impact inflammation in the brain.


SPEAKERS

  • Great Kemmer, PharmD, BCACP
    Ambulatory Pharmacist Clinician, Penn Medicine Lancaster General Health
  • Lora Ferguson, PharmD, MBAHM, DPLA, BCOP, CSP
    Manager of Clinical Ambulatory Pharmacy Operations, Valley Medical Center
  • Paris Smith, PharmD, BCACP, CDCES
    Ambulatory Pharmacist, Parkview Health

LISTEN ON


iTunes      Google            Spotify      TuneIn      iHeart Radio


The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP Podcasts